Literature DB >> 12437373

Structural analysis of the inhibition of Cdk4 and Cdk6 by p16(INK4a) through molecular dynamics simulations.

Oscar Villacañas1, Juan J Pérez, Jaime Rubio-Martínez.   

Abstract

Cyclin-dependent kinases 4, 6 and 2 (Cdk4/6/2), are proteins that lead progression through the G1-S transition, a step strictly regulated in the process of cell proliferation. The p16(INK4a) tumor suppressor, whose expression is inhibited in a high number of cancers, binds to Cdk4/6 and inhibits phosphorylation of the retinoblastoma protein, forcing cells to remain in the G1 phase and therefore, arresting cell division. Accordingly, the design of small compounds mimicking the inhibition of p16(INK4a) appears to be a promising way to treat cancer. In order to get some insight into the key interactions governing recognition between different cyclin-dependent kinases and the p16(INK4a) tumor suppressor, the present work reports the results of molecular dynamics simulations of both, the Cdk6-p16(INK4a) complex and the Cdk4-p16(INK4a) complex, respectively at 300 K. Most of the key interactions observed, were already anticipated in the analysis of the crystal structure of Cdk6-p16(INK4a). However, a few different features found out from the analysis of these calculations provide a better understanding of the role of the T-loop conformation, a fragment of Cdks, and the way the ATP binding-site is distorted upon binding of p16(INK4a).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12437373     DOI: 10.1080/07391102.2002.10506853

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  9 in total

1.  Cyclin-dependent kinases 4 and 6 control tumor progression and direct glucose oxidation in the pentose cycle.

Authors:  Miriam Zanuy; Antonio Ramos-Montoya; Oscar Villacañas; Nuria Canela; Anibal Miranda; Esther Aguilar; Neus Agell; Oriol Bachs; Jaime Rubio-Martinez; Maria Dolors Pujol; Wai-Nang P Lee; Silvia Marin; Marta Cascante
Journal:  Metabolomics       Date:  2011-07-08       Impact factor: 4.290

2.  Docking and quantitative structure-activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors.

Authors:  Julio Caballero; Miguel Quiliano; Jans H Alzate-Morales; Mirko Zimic; Eric Deharo
Journal:  J Comput Aided Mol Des       Date:  2011-04-13       Impact factor: 3.686

3.  Cellular senescence and senescence-associated secretory phenotype: comparison of idiopathic pulmonary fibrosis, connective tissue disease-associated interstitial lung disease, and chronic obstructive pulmonary disease.

Authors:  Ryo Okuda; Kazutetsu Aoshiba; Hidekazu Matsushima; Takashi Ogura; Koji Okudela; Kenichi Ohashi
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

4.  Investigation of the structure requirement for 5-HT₆ binding affinity of arylsulfonyl derivatives: a computational study.

Authors:  Ming Hao; Yan Li; Hanqing Li; Shuwei Zhang
Journal:  Int J Mol Sci       Date:  2011-08-08       Impact factor: 5.923

5.  Gene regulatory network underlying the immortalization of epithelial cells.

Authors:  Luis Fernando Méndez-López; Jose Davila-Velderrain; Elisa Domínguez-Hüttinger; Christian Enríquez-Olguín; Juan Carlos Martínez-García; Elena R Alvarez-Buylla
Journal:  BMC Syst Biol       Date:  2017-02-16

Review 6.  A Review of Key Biological and Molecular Events Underpinning Transformation of Melanocytes to Primary and Metastatic Melanoma.

Authors:  Louise A Jackett; Richard A Scolyer
Journal:  Cancers (Basel)       Date:  2019-12-17       Impact factor: 6.639

7.  Simulation of different truncated p16(INK4a) forms and in silico study of interaction with Cdk4.

Authors:  Najmeh Fahham; Mohammad Hossein Ghahremani; Soroush Sardari; Behrouz Vaziri; Seyed Nasser Ostad
Journal:  Cancer Inform       Date:  2008-12-03

8.  Prospecting for novel plant-derived molecules of Rauvolfia serpentina as inhibitors of Aldose Reductase, a potent drug target for diabetes and its complications.

Authors:  Shivalika Pathania; Vinay Randhawa; Ganesh Bagler
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

9.  New insights into the structural dynamics of the kinase JNK3.

Authors:  Pankaj Mishra; Stefan Günther
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.